Michael G. King Jr. - 30 Nov 2023 Form 4 Insider Report for SAB Biotherapeutics, Inc. (SABS)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Michael G. King, Jr.
Issuer symbol
SABS
Transactions as of
30 Nov 2023
Net transactions value
+$4,500
Form type
4
Filing time
30 Nov 2023, 17:00:07 UTC
Previous filing
03 Nov 2023
Next filing
23 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SABS Common Stock Purchase $4,500 +5,000 $0.9000 5,000 30 Nov 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 5,000 shares of the Issuer's common stock, par value $0.0001 per share, acquired by the reporting person in an open market transaction.